Evidence map›Paper›PMID 28596949›Full record

ReviewClinical and translational imaging2017

New methodologies for the preparation of carbon-11 labeled radiopharmaceuticals.

Kenneth Dahl, Christer Halldin, Magnus Schou

Open access · hybridAbstract readReview
In one paragraph

Review in Clinical and translational imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 96 citations in OpenAlex.

  1. Pooled it
  2. It's a Gas: Bioconjugation With Vapor-Phase Reagents.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  3. Trifluoromethylation of alkyl electrophiles withScience (New York, N.Y.) · 2025
    Article
  4. Review
  5. Review
  6. [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Development and Optimization ofACS pharmacology & translational science · 2023
    Review
  11. Article
  12. Review
  13. Review
  14. Radiochemical Synthesis and Evaluation of 3-[ACS chemical neuroscience · 2022
    Article
  15. Article
  16. Review
  17. [Nature · 2022
    Article
  18. A new concept for the production ofEJNMMI radiopharmacy and chemistry · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kenneth DahlDepartment of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Hospital, Karolinska Institutet, 171 76 Stockholm, Sweden.ORCID 0000-0003-2948-2042
Christer HalldinDepartment of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Hospital, Karolinska Institutet, 171 76 Stockholm, Sweden.
Magnus SchouDepartment of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Hospital, Karolinska Institutet, 171 76 Stockholm, Sweden.
Karolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis short review aims to cover the more recent and promising developments of carbon-11 (

methodsA survey of the literature was undertaken to identify articles focusing on methodological development in

resultsFrom the literature, it is clear that the majority of

conclusionRadiochemistry is the foundation of PET imaging which relies on the administration of a radiopharmaceutical. The demand for new radiopharmaceuticals for clinical PET imaging is increasing, and

Indexed as

Carbon-11Isotopic labelingPETRadiochemistryRadiopharmaceuticals

Identifiers

PMID28596949
PMCPMC5437136
OpenAlexW2591246371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.